Skip to main content
. 2013 Feb 21;9(2):e1002899. doi: 10.1371/journal.pcbi.1002899

Table 3. Novel resistance conferring mutations derived from the dataset (NRTI).

Mutation 3TC ABC AZT D4T DDC DDI TDF FTC Average Log FC
I63V* 0.22 n/a 1.07 0.53 n/a 0.52 0.01 0.36 0.45
I202M* 0.23 n/a 0.73 0.68 0.51 0.57 0.45 0.39 0.51
R206M 0.90 0.42 0.54 0.01 0.15 0.17 0.24 0.92 0.42
T216M 0.88 0.51 0.66 0.12 0.20 0.27 0.38 0.94 0.50
E298K* 0.33 0.43 0.44 0.38 0.65 0.32 n/a n/a 0.43
Average Susceptibility 0.51 0.45 0.69 0.34 0.38 0.37 0.27 0.65 -

The value in the different drug columns indicates the average Log FC in the presence of this mutation, when not available in the dataset the value is denoted ‘n/a’. Mutations indicated with an asterisk were incompletely tested on all drugs in the dataset. Like the NNRTI resistance mutations, each mutation displays a different resistance profile over all drugs. AZT is seen to be the most susceptible (average Log FC 0.69) and TDF the least susceptible (average Log FC 0.27).